Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
A groundbreaking Nature study shows that COVID-19 mRNA vaccines may enhance cancer immunotherapy by unleashing powerful immune responses, turning resistant tumors into treatment-ready targets — a discovery that could transform oncology forever.
Australian researchers identify key nervous system components, CGRP and RAMP1, that drive colorectal and stomach cancer growth, highlighting opportunities to repurpose existing migraine drugs as potential cancer therapies.
Discover the latest cancer research breakthroughs from Memorial Sloan Kettering (MSK) presented at ESMO 2025, including new therapies for lung, pancreatic, and mismatch repair–deficient solid tumors. Explore the promising clinical results that may redefine future cancer care.
Scientists at the Francis Crick Institute and Vividion Therapeutics have developed a new compound that blocks cancer’s growth signal without damaging healthy cells. The discovery, published in Science, marks a major advance in safer, targeted cancer treatments now entering human clinical trials.